• Publications
  • Influence
Dystrophin-Deficient Cardiomyopathy.
Dystrophinopathies are a group of distinct neuromuscular diseases that result from mutations in the structural cytoskeletal Dystrophin gene. Dystrophinopathies include Duchenne muscular dystrophyExpand
  • 110
  • 11
Improved survival and decreasing incidence of adverse events with the HeartMate II left ventricular assist device as bridge-to-transplant therapy.
BACKGROUND Pulsatile left ventricular assist devices (LVADs) are effective as bridge-to-transplant therapy, but they are limited by their large size and lack of durability. Smaller, more durable,Expand
  • 256
  • 6
  • Open Access
Experience with the Levitronix CentriMag circulatory support system as a bridge to decision in patients with refractory acute cardiogenic shock and multisystem organ failure.
OBJECTIVE Patients with refractory acute cardiogenic shock and multisystem organ failure have a poor outcome with implantation of permanent ventricular assist devices. We review our experience withExpand
  • 165
  • 5
Low thromboembolic risk for patients with the Heartmate II left ventricular assist device.
OBJECTIVE Thromboembolic events can occur in up to 20% of patients with a left ventricular assist device. The aggressive use of anticoagulation with newer continuous-flow devices has potentiallyExpand
  • 164
  • 4
Effects on pre- and posttransplant pulmonary hemodynamics in patients with continuous-flow left ventricular assist devices.
OBJECTIVE Pulsatile left ventricular assist devices have been shown to effectively reduce pulmonary hypertension in patients with end-stage heart failure. However, it remains to be seen whether newerExpand
  • 66
  • 4
Effects of the HeartMate II continuous-flow left ventricular assist device on right ventricular function.
BACKGROUND Continuous-flow devices have become the standard of care for mechanical circulatory support for end-stage heart failure patients because of improved survival and durability. The effects ofExpand
  • 103
  • 3
  • Open Access
ATP Production Rate via Creatine Kinase or ATP Synthase In Vivo: A Novel Superfast Magnetization Saturation Transfer Method
Rationale: 31P magnetization saturation transfer (MST) experiment is the most widely used method to study ATP metabolism kinetics. However, its lengthy data acquisition time greatly limits the wideExpand
  • 49
  • 3
Effects of centrifugal, axial, and pulsatile left ventricular assist device support on end-organ function in heart failure patients.
PURPOSE Newer continuous-flow left ventricular assist devices (LVAD) have the advantage of smaller size and increased durability. Questions remain regarding the safety and effects of long-termExpand
  • 141
  • 2
Lessons learned from experience with over 100 consecutive HeartMate II left ventricular assist devices.
BACKGROUND Continuous-flow left ventricular assist devices (LVADs) such as the HeartMate II have become the therapy of choice in patients with end-stage heart failure. The aim of this study is toExpand
  • 87
  • 2
Postcardiac transplant survival in the current era in patients receiving continuous-flow left ventricular assist devices.
OBJECTIVES Continuous-flow left ventricular assist devices have become the standard of care for patients with heart failure requiring mechanical circulatory support as a bridge to transplant.Expand
  • 54
  • 2